Life Science

An uncommon, naturally occurring PUFA, inhibits the binding of [3H]-LTB4 to porcine neutrophil membranes with a Ki value of 3 &microM.

The male-specific mating pheromone of the fruit fly D. melanogaster acts selectively through the Or67d odorant receptor to control mating behavior in both male and female fruit flies.

The male-specific mating pheromone of the fruit fly D. melanogaster acts selectively through the Or67d odorant receptor to control mating behavior in both male and female fruit flies.

The male-specific mating pheromone of the fruit fly D. melanogaster acts selectively through the Or67d odorant receptor to control mating behavior in both male and female fruit flies.

The male-specific mating pheromone of the fruit fly D. melanogaster acts selectively through the Or67d odorant receptor to control mating behavior in both male and female fruit flies.

Thromboxane A2 (TXA2), produced from arachidonic acid, causes irreversible platelet aggregation, vascular, and bronchial smooth muscle contraction. TXA2 is rapidly hydrolyzed non-enzymatically to form TXB2.

Thromboxane A2 (TXA2), produced from arachidonic acid, causes irreversible platelet aggregation, vascular, and bronchial smooth muscle contraction. TXA2 is rapidly hydrolyzed non-enzymatically to form TXB2.

The 11-dehydro TXB2 Quant-PAK has been designed for the convenient, precise quantification of 11-dehydro TXB2 by GC- or LC-MS. It includes a 50 &microg vial of 11-dehydro TXB2-d4 and a precisely weighed vial of unlabeled 11-dehydro TXB2, with the

Thromboxane B2 (TXB2) is released in substantial quantities from aggregating platelets and metabolized during circulation to 11-dehydro TXB2 and 2,3-dinor TXB2. 11-dehydro TXB2 is one of the main plasma metabolites of TXB2 and can be used as a

Thromboxane B2 (TXB2) is released in substantial quantities from aggregating platelets and metabolized during circulation to 11-dehydro TXB2 and 2,3-dinor TXB2. 11-dehydro TXB2 is one of the main plasma metabolites of TXB2 and can be used as a

Thromboxane B2 (TXB2) is released in substantial quantities from aggregating platelets and metabolized during circulation to 11-dehydro TXB2 and 2,3-dinor TXB2. 11-dehydro TXB2 is one of the main plasma metabolites of TXB2 and can be used as a

Thromboxane B2 (TXB2) is released in substantial quantities from aggregating platelets and metabolized during circulation to 11-dehydro TXB2 and 2,3-dinor TXB2. 11-dehydro TXB2 is one of the main plasma metabolites of TXB2 and can be used as a